NCT01081405View on ClinicalTrials.gov

Total Lymphoid Irradiation and Anti-Thymocyte Globulin in the Allogeneic Hematopoietic Cell Transplantation

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
HEMATOLOGIC MALIGNANCIES
Interventions
OTHER

TOTAL LYMPHOID IRRADIATION

Allogeneic Hematopoietic Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-Thymocyte Globulin for Patients with Hematologic Malignancies

Trial Locations (1)

10126

A.O.U. Città della Salute e della Scienza di Torino, Torino

All Listed Sponsors
lead

Fondazione EMN Italy Onlus

OTHER

NCT01081405 - Total Lymphoid Irradiation and Anti-Thymocyte Globulin in the Allogeneic Hematopoietic Cell Transplantation | Biotech Hunter | Biotech Hunter